Jim Simons Amphastar Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 489,400 shares of AMPH stock, worth $21.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

489,400

Previous 537,700 8.98%

Holding current value

$21.6 Million

Previous $21.5 Million 10.42%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$36.99 - $50.09 $1.79 Million - $2.42 Million	-48,300 Reduced 8.98%	489,400 $23.8 Million
Q2 2024 Aug 09, 2024	SELL	$38.65 - $43.48 $2.37 Million - $2.67 Million	-61,400 Reduced 10.25%	537,700 $21.5 Million
Q1 2024 May 13, 2024	SELL	$42.85 - $63.45 $1.83 Million - $2.72 Million	-42,800 Reduced 6.67%	599,100 $26.3 Million
Q4 2023 Feb 13, 2024	BUY	$44.49 - $62.93 $1.73 Million - $2.44 Million	38,800 Added 6.43%	641,900 $39.7 Million
Q3 2023 Nov 14, 2023	BUY	$45.51 - $65.0 $5.03 Million - $7.18 Million	110,517 Added 22.44%	603,100 $27.7 Million
Q2 2023 Aug 11, 2023	SELL	$35.77 - $58.38 $150,842 - $246,188	-4,217 Reduced 0.85%	492,583 $28.3 Million
Q1 2023 May 12, 2023	BUY	$27.99 - $37.92 $1.38 Million - $1.87 Million	49,400 Added 11.04%	496,800 $18.6 Million
Q4 2022 Feb 13, 2023	BUY	$27.93 - $31.27 $379,848 - $425,272	13,600 Added 3.14%	447,400 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $741,364 - $1.02 Million	26,900 Added 6.61%	433,800 $12.2 Million
Q2 2022 Aug 12, 2022	BUY	$29.79 - $42.29 $2.93 Million - $4.15 Million	98,200 Added 31.81%	406,900 $14.2 Million
Q1 2022 May 13, 2022	BUY	$22.96 - $36.45 $433,944 - $688,905	18,900 Added 6.52%	308,700 $11.1 Million
Q4 2021 Feb 11, 2022	BUY	$18.14 - $23.29 $255,774 - $328,389	14,100 Added 5.11%	289,800 $6.75 Million
Q3 2021 Nov 12, 2021	BUY	$17.83 - $21.49 $509,937 - $614,614	28,600 Added 11.57%	275,700 $5.24 Million
Q2 2021 Aug 13, 2021	BUY	$17.11 - $20.92 $367,865 - $449,780	21,500 Added 9.53%	247,100 $4.98 Million
Q1 2021 May 13, 2021	SELL	$17.21 - $20.65 $1.5 Million - $1.8 Million	-87,000 Reduced 27.83%	225,600 $4.13 Million
Q4 2020 Feb 10, 2021	SELL	$17.76 - $21.24 $1.17 Million - $1.4 Million	-65,700 Reduced 17.37%	312,600 $6.29 Million
Q3 2020 Nov 13, 2020	SELL	$17.99 - $22.22 $2.39 Million - $2.96 Million	-133,000 Reduced 26.01%	378,300 $7.09 Million
Q2 2020 Aug 13, 2020	SELL	$14.25 - $22.46 $3.24 Million - $5.11 Million	-227,300 Reduced 30.77%	511,300 $11.5 Million
Q1 2020 May 14, 2020	SELL	$12.66 - $20.08 $1.2 Million - $1.9 Million	-94,400 Reduced 11.33%	738,600 $11 Million
Q4 2019 Feb 13, 2020	BUY	$17.07 - $20.64 $1.75 Million - $2.11 Million	102,300 Added 14.0%	833,000 $16.1 Million
Q3 2019 Nov 13, 2019	BUY	$19.12 - $22.62 $2.73 Million - $3.23 Million	142,700 Added 24.27%	730,700 $14.5 Million
Q2 2019 Aug 12, 2019	BUY	$18.92 - $22.96 $2.77 Million - $3.36 Million	146,400 Added 33.15%	588,000 $12.4 Million
Q1 2019 May 14, 2019	BUY	$19.46 - $25.28 $2.56 Million - $3.32 Million	131,500 Added 42.41%	441,600 $9.02 Million
Q4 2018 Feb 13, 2019	BUY	$17.72 - $22.51 $5.49 Million - $6.98 Million	310,100 New	310,100 $6.17 Million

Others Institutions Holding AMPH

# of Institutions

287

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.16B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account